Links

Hatch Waxman turns 40. FDA: Integrating RCT into routine clinical practice.Cost of care under Medicare vs. Medicaid.The Less-Efficient Market Hypothesis.Semaglutide and COVID-19.Statistical Modeling, Causal Inference, and Social Science turns 20.

Read More

‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer

Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR T-therapy with properties that could improve safety, efficacy, and durability. The post ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood…

Read More

Links

Measles outbreak expands to 19 states.Commercial health plan coverage of accelerated approval drugs…and a recent case study.Extending IRA drug price negotiation to commercial plans?‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study’Why are LLMs so good at economics?Most expensive states to start a business.

Read More